Report cover image

North America Implantable Cardioverter Defibrillator Market Size, Share & Industry Trends Analysis Report By Type, By Product Type, By NYHA Class, By End-Use (Hospitals, Ambulatory Surgical Centers), By Country and Growth Forecast, 2023 - 2030

Publisher Knowledge Based Value (KBV) Research
Published Oct 31, 2023
Length 128 Pages
SKU # KBV18339084

Description

North America Implantable Cardioverter Defibrillator Market Size, Share & Industry Trends Analysis Report By Type, By Product Type, By NYHA Class, By End-Use (Hospitals, Ambulatory Surgical Centers), By Country and Growth Forecast, 2023 - 2030


The North America Implantable Cardioverter Defibrillator Market would witness market growth of 5.4% CAGR during the forecast period (2023-2030).

Technological advances and product innovations, such as Epsila EV MRI SureScan and Aurora Extravascular (EV)-ICD MRI SureScan by Medtronic, offer optimistic solutions with reduced complications and enhanced placement techniques. Moreover, the prevalence of sudden cardiac arrest is on the rise in emerging nations. The prevalence of sudden cardiac arrest is anticipated to rise due to the growth of specific risk factors like smoking, obesity, and sedentary lifestyle, which is anticipated to raise demand for ICD during the forecast period.

The ICD has seen continuous technological advancements, leading to smaller, more efficient devices with improved battery life. These advancements have made ICDs more comfortable for patients and easier for healthcare providers to implant. Miniaturization of ICDs has been a significant trend, allowing for less invasive procedures and reduced scarring. Smaller devices also improve patient comfort and reduce the risk of infection. Remote monitoring capabilities have become increasingly important in ICDs. These devices can transmit data and alerts to healthcare providers, allowing for proactive patient care and early detection of potential issues.

North America has a significant prevalence of cardiovascular diseases, including arrhythmias, heart failure, and coronary artery disease. ICDs are essential in preventing sudden cardiac death in patients with these conditions. North America is known for its advanced medical technology and innovation. Manufacturers in the region and around the world develop state-of-the-art ICDs with features such as remote monitoring, MRI compatibility, and sophisticated algorithms for arrhythmia detection. The adoption and utilization of ICDs in North America continue to grow as healthcare providers and patients recognize the value of these devices in managing cardiac conditions and reducing the risk of sudden cardiac death. Advances in technology, research, and patient care contribute to the ongoing development of the ICD in the region.

The US market dominated the North America Implantable Cardioverter Defibrillator Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,554.6 million by 2030. The Canada market is exhibiting a CAGR of 7.8% during (2023 - 2030). Additionally, The Mexico market would experience a CAGR of 6.9% during (2023 - 2030).

Based on Type, the market is segmented into Biventricular Devices, Dual Chamber ICDs and Single Chamber ICDs. Based on Product Type, the market is segmented into Transvenous and Subcutaneous. Based on NYHA Class, the market is segmented into NYHA Class II and NYHA Class III. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Biotronik SE & Co. KG, Boston Scientific Corporation, MicroPort Scientific Corporation, Stryker Corporation, ZOLL Medical Corporation (Asahi Kasei Corporation), LivaNova PLC, Koninklijke Philips N.V. and Getinge AB.

Scope of the Study

Market Segments covered in the Report:

By Type
  • Biventricular Devices
  • Dual Chamber ICDs
  • Single Chamber ICDs
By Product Type
  • Transvenous
  • Subcutaneous
By NYHA Class
  • NYHA Class II
  • NYHA Class III
By End-use
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • Abbott Laboratories
  • Medtronic PLC
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • MicroPort Scientific Corporation
  • Stryker Corporation
  • ZOLL Medical Corporation (Asahi Kasei Corporation)
  • LivaNova PLC
  • Koninklijke Philips N.V.
  • Getinge AB
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

128 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Implantable Cardioverter Defibrillator Market, by Type
1.4.2 North America Implantable Cardioverter Defibrillator Market, by Product Type
1.4.3 North America Implantable Cardioverter Defibrillator Market, by NYHA Class
1.4.4 North America Implantable Cardioverter Defibrillator Market, by End-use
1.4.5 North America Implantable Cardioverter Defibrillator Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Implantable Cardioverter Defibrillator Market
Chapter 5. North America Implantable Cardioverter Defibrillator Market, By Type
5.1 North America Biventricular Devices Market, By Country
5.2 North America Dual Chamber ICDs Market, By Country
5.3 North America Single Chamber ICDs Market, By Country
Chapter 6. North America Implantable Cardioverter Defibrillator Market, By Product Type
6.1 North America Transvenous Market, By Country
6.2 North America Subcutaneous Market, By Country
Chapter 7. North America Implantable Cardioverter Defibrillator Market, By NYHA Class
7.1 North America NYHA Class II Market, By Country
7.2 North America NYHA Class III Market, By Country
Chapter 8. North America Implantable Cardioverter Defibrillator Market, By End-use
8.1 North America Hospitals Market, By Country
8.2 North America Ambulatory Surgical Centers Market, By Country
8.3 North America Others Market, By Country
Chapter 9. North America Implantable Cardioverter Defibrillator Market, By Country
9.1 US Implantable Cardioverter Defibrillator Market
9.1.1 US Implantable Cardioverter Defibrillator Market, By Type
9.1.2 US Implantable Cardioverter Defibrillator Market, By Product Type
9.1.3 US Implantable Cardioverter Defibrillator Market, By NYHA Class
9.1.4 US Implantable Cardioverter Defibrillator Market, By End-use
9.2 Canada Implantable Cardioverter Defibrillator Market
9.2.1 Canada Implantable Cardioverter Defibrillator Market, By Type
9.2.2 Canada Implantable Cardioverter Defibrillator Market, By Product Type
9.2.3 Canada Implantable Cardioverter Defibrillator Market, By NYHA Class
9.2.4 Canada Implantable Cardioverter Defibrillator Market, By End-use
9.3 Mexico Implantable Cardioverter Defibrillator Market
9.3.1 Mexico Implantable Cardioverter Defibrillator Market, By Type
9.3.2 Mexico Implantable Cardioverter Defibrillator Market, By Product Type
9.3.3 Mexico Implantable Cardioverter Defibrillator Market, By NYHA Class
9.3.4 Mexico Implantable Cardioverter Defibrillator Market, By End-use
9.4 Rest of North America Implantable Cardioverter Defibrillator Market
9.4.1 Rest of North America Implantable Cardioverter Defibrillator Market, By Type
9.4.2 Rest of North America Implantable Cardioverter Defibrillator Market, By Product Type
9.4.3 Rest of North America Implantable Cardioverter Defibrillator Market, By NYHA Class
9.4.4 Rest of North America Implantable Cardioverter Defibrillator Market, By End-use
Chapter 10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.5.2 Trails and Approvals:
10.1.6 SWOT Analysis
10.2 Medtronic PLC
10.2.1 Company overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 SWOT Analysis
10.3 Biotronik SE & Co. KG
10.3.1 Company Overview
10.3.2 SWOT Analysis
10.4 Boston Scientific Corporation
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 SWOT Analysis
10.5 MicroPort Scientific Corporation
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 SWOT Analysis
10.6 Stryker Corporation
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Product Launches and Product Expansions:
10.6.6 SWOT Analysis
10.7 ZOLL Medical Corporation (Asahi Kasei Corporation)
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expense
10.7.5 Recent strategies and developments:
10.7.5.1 Acquisition and Mergers:
10.7.6 SWOT Analysis
10.8 LivaNova PLC
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expense
10.8.5 SWOT Analysis
10.9 Koninklijke Philips N.V.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent strategies and developments:
10.9.5.1 Acquisition and Mergers:
10.9.6 SWOT Analysis
10.10. Getinge AB
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis
10.10.4 Research & Development Expense
10.10.5 SWOT Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us